JERSEY, Channel Islands, Jan. 24, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2016 will be released after market close on Monday, February 6, 2017.
Quotient will host a conference call on Tuesday, February 7, at 8:30 a.m. Eastern Time to discuss its third quarter fiscal 2017 financial results. Participants may access the call by dialing 1-877-407-0784 in the U.S. or 1-201-689-8560 outside the U.S. The conference call will be webcast live on the Company's website at www.quotientbd.com.
A replay of this conference call will be available through February 14, 2017 by dialing 1-844-512-2921 in the U.S. or 1-412-317-6671 outside the U.S. The replay access code is 13653585.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQ™ technology platform to address the $3.4 billion global transfusion diagnostics market. The Company's operations are based in Switzerland, Scotland and the US.
The Quotient logo and MosaiQ™ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.
CONTACT: Paul Cowan, Chairman & Chief Executive Officer — [email protected]; +1 267 756 0842


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Britain Courts Anthropic Amid US Defense Department Dispute
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 



